Private Placement

After a pivotal 2025, Lithium Ionic is advancing its low-cost, high-return Bandeira project toward construction, aiming to become a key lithium supplier.

After nearly half a century, the JLPGA tour is back in Taiwan, fueled by tech giants Foxconn and SoftBank and a record-breaking US$2 million purse.

One year in, Taiwan's state-backed startup hub is embedding its hardware prowess into U.S. AI innovation, deepening a critical tech alliance.

European Investment Bank and IFC fuel Alta Semper's new fund, signaling a major push to scale private healthcare solutions across the African continent.

Medtech firm IMPLANET reports a landmark €12.5M revenue year, fueled by strong international sales, US growth, and a strategic pivot into robotics.

With new funding from BroadOak Capital Partners, Axol Bioscience is set to expand its revolutionary iPSC-based disease models in the US market.

Propanc Biopharma is taking a 100-year-old cancer treatment concept into modern human trials, targeting advanced tumors and expanding into fibrosis.

Unveiled at CES 2026, this award-winning expandable home on wheels promises AI-powered, self-sufficient living for a new generation of nomads.

A novel vaccine protects shrimp by immunizing their parents, offering a solution to devastating outbreaks and a path to sustainable global protein production.

With a new $290M facility from MUFG, Summit Ridge Energy is accelerating its solar expansion, promising new U.S. jobs, grid stability, and faster power.

MedTech firm Lifeward is acquiring Oramed's oral insulin tech, despite a past trial failure, in a high-stakes deal that could redefine both companies.

American Pride Bank is simplifying complex construction financing for investors and the self-employed, unlocking new opportunities in real estate.

As extreme weather disrupts learning, a new research-backed guide helps schools protect student well-being and academic continuity.

French insurer Groupama launches a pioneering catastrophe bond targeting hail, a novel financial shield against escalating climate-driven storm losses.

With a new lineup including a $699 model, ZWHAND's debut at CES 2026 could accelerate the mass adoption of dexterous robots in every field.

Adimab's stellar 2025 reveals its crucial role as the hidden tech platform driving drug discovery for giants like Lilly and Regeneron.

Pimicotinib, a once-daily pill for tenosynovial giant cell tumor, gains FDA review, offering new hope for patients beyond invasive surgery.

Mezo is offering token rewards to lure over $11B in wrapped Bitcoin from Ethereum, aiming to build a native Bitcoin DeFi ecosystem and fulfill a long-held vision.

A new drill-free cavity treatment is regenerating teeth, attracting Wall Street, and aiming to solve a global health crisis. This is the story of Curodont™.

With new executive leadership, AI firm HealthLeap aims to accelerate its mission of improving patient outcomes and hospital finances nationwide.